Site specific tumor microenvironments modulate the immune checkpoint inhibitors response in models of CT26 colon carcinoma

被引：0
|
作者：
Zhao, Fei
Thompson, Caitlin
Barnes, Nicole
Roques, Jose
Coleman, Terrence
Rowe, Tyler
Kolb, Joseph
Hall, Chassidy
Fadden, Patrick
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-2872
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2872
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
    Lu, Li-Chun
    Hsu, Chiun
    Shao, Yu-Yun
    Chao, Yee
    Yen, Chia-Jui
    Shih, I-Lun
    Hung, Yi-Ping
    Chang, Chun-Jung
    Shen, Ying-Chun
    Guo, Jhe-Cyuan
    Liu, Tsung-Hao
    Hsu, Chih-Hung
    Cheng, Ann-Lii
    LIVER CANCER, 2019, 8 (06) : 480 - 490
  • [2] Soluble OX40L favors tumor rejection in CT26 colon carcinoma model
    Serebrovskaya, Ekaterin O.
    Yuzhakova, Diana V.
    Ryumina, Alina P.
    Druzhkova, Irina N.
    Sharonov, George V.
    Kotlobay, Alexey A.
    Zagaynova, Elena V.
    Lukyanov, Sergey A.
    Shirmanova, Marina V.
    CYTOKINE, 2016, 84 : 10 - 16
  • [3] CT26 murine colon carcinoma expressing the red fluorescent protein KillerRed as a highly immunogenic tumor model
    Yuzhakova, Diana V.
    Shirmanova, Marina V.
    Serebrovskaya, Ekaterina O.
    Lukyanov, Konstantin A.
    Druzhkova, Irina N.
    Shakhov, Boris E.
    Lukyanov, Sergey A.
    Zagaynova, Elena V.
    JOURNAL OF BIOMEDICAL OPTICS, 2015, 20 (08)
  • [4] Ketogenic diet inhibits tumor growth by enhancing immune response, attenuating immunosuppression, inhibiting angiogenesis and EMT in CT26 colon tumor allografts mouse model
    Sun, Wei
    Yang, Junrong
    Liu, Bingyi
    Liu, Quiqin
    Wang, Ting
    Wang, Qingpeng
    Liu, Min
    Li, Lanjie
    Wang, Zhengping
    Li, Sen
    Siebert, Hans-Christian
    Zhang, Ning
    JOURNAL OF FUNCTIONAL FOODS, 2022, 92
  • [5] Combination of pioglitazone and dendritic cell to optimize efficacy of immune cell therapy in CT26 tumor models
    Tokhanbigli, Samaneh
    Alavifard, Helia
    Aghdaei, Hamid Asadzadeh
    Zali, Mohammad Reza
    Baghaei, Kaveh
    BIOIMPACTS, 2023, 13 (04) : 333 - 346
  • [6] THE TUMOR MICROBIOME CORRELATES WITH RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN RENAL CELL CARCINOMA
    Wheeler, Caroline
    Yang, Yuanquan
    Spakowicz, Daniel
    Hoyd, Rebecca
    Li, Mingjia
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A988 - A989
  • [7] Clonal variation in interferon response determines the outcome of oncolytic virotherapy in mouse CT26 colon carcinoma model
    J J Ruotsalainen
    M U Kaikkonen
    M Niittykoski
    M W Martikainen
    C G Lemay
    J Cox
    N S De Silva
    A Kus
    T J Falls
    J-S Diallo
    F Le Boeuf
    J C Bell
    S Ylä-Herttuala
    A E Hinkkanen
    M J Vähä-Koskela
    Gene Therapy, 2015, 22 : 65 - 75
  • [8] Clonal variation in interferon response determines the outcome of oncolytic virotherapy in mouse CT26 colon carcinoma model
    Ruotsalainen, J. J.
    Kaikkonen, M. U.
    Niittykoski, M.
    Martikainen, M. W.
    Lemay, C. G.
    Cox, J.
    De Silva, N. S.
    Kus, A.
    Falls, T. J.
    Diallo, J-S
    Le Boeuf, F.
    Bell, J. C.
    Yla-Herttuala, S.
    Hinkkanen, A. E.
    Vaha-Koskela, M. J.
    GENE THERAPY, 2015, 22 (01) : 65 - 75
  • [9] IL-12-gene expression by CT26 colon carcinoma cells induces an anti-tumor immune memory effective in the rejection or syngeneic mammary tumor cells
    Adris, S
    Bravo, A
    Klein, S
    Jasnis, M
    Carbone, C
    Chernajovsky, Y
    Podhajcer, O
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 363 - 363
  • [10] Tumor-Specific and Tumor-Agnostic Molecular Signatures Associated With Response to Immune Checkpoint Inhibitors
    Schlauch, Daniel
    Fu, Xiaotong
    Jones, Suzanne F.
    Burris, Howard A.
    Spigel, David R.
    Reeves, James
    McKenzie, Andrew J.
    JCO PRECISION ONCOLOGY, 2021, 5 : 1625 - 1638
12345